Literature DB >> 31517846

Safety and efficacy of acupuncture for the treatment of chronic obstructive pulmonary disease: A systematic review protocol.

Mingxia Yu1, Longxia Gao1, Yanhua Kong2, Yue Yan2, Qi Shi2, Dongxu Si1, Haipeng Bao3, Huizhuo Sun1, Lei Li1, Youlin Li2.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a common chronic respiratory disease with increasing morbidity and mortality that cause huge social and economic loss. Although recommended by guidelines, pulmonary rehabilitation has not been widely applied in clinics because of its inherent limitations. Acupuncture therapy (AT) as one of the most popular treatments in traditional Chinese medicine has been used to treat COPD. We aim to evaluate the safety and efficacy of acupuncture in the treatment of COPD.
METHODS: Web of science, PubMed, Springer, Medline, Cochrane Library, EBASE, WHO International Clinical Trials Registry Platform (ICTRP), China National Knowledge Infrastructure Database (CNKI), Wan Fang Database, Chinese Scientific Journal Database (VIP), and Chinese Biomedical Literature Database will be searched from their inception to May 10, 2019. Randomized controlled trials that evaluated the safety and efficacy of acupuncture for the treatment on patients with COPD will be included. The primary outcome measures will include Dyspnea scores, lung function and blood eosinophils. The secondary outcome measures will include St George's Respiratory Questionnaire and 6-minute walk distance. Study selection, data extraction, and risk of bias assessment will be independently undertaken, respectively. Statistical analysis will be conducted by RevMan software (version 5.3).
RESULTS: This study will provide high-quality synthesis based on current evidence of acupuncture treatment for COPD in several aspects, including symptom score, quality of life score, side effects and laboratory examination, such as lung function text, blood eosinophils (EOS) etc.
CONCLUSION: : The results of this study will provide updated evidence for weather acupuncture is an effective and safe intervention for COPD. ETHICS AND DISSEMINATION: It is not necessary for this systematic review to acquire an ethical approval. This review will be disseminated in a peer-reviewed journal or conference presentation. PROSPERO REGISTRATION NUMBER: PROSPERO CRD42019136087.

Entities:  

Mesh:

Year:  2019        PMID: 31517846      PMCID: PMC6750299          DOI: 10.1097/MD.0000000000017112

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  33 in total

Review 1.  Molecular mechanisms of glucocorticoid action: what is important?

Authors:  R Newton
Journal:  Thorax       Date:  2000-07       Impact factor: 9.139

2.  Chronic obstructive pulmonary disease: current burden and future projections.

Authors:  A D Lopez; K Shibuya; C Rao; C D Mathers; A L Hansell; L S Held; V Schmid; S Buist
Journal:  Eur Respir J       Date:  2006-02       Impact factor: 16.671

3.  [Electroacupuncture Intervention Improved Pulmonary Function via Promoting Immunoregulation in Chronic Obstructive Pulmonary Disease Rats].

Authors:  Juan Tong; Fu-Chu Chen; Gui-Yuan Li; Xiang-Ao Kong; Ying He; Hong Yao
Journal:  Zhen Ci Yan Jiu       Date:  2018-04-25

4.  [Electroacupuncture Improves Pulmonary Function of Rats with Chronic Obstructive Pulmonary Disease by Down-regulating Inflammatory Reaction and Expression of Macrophage Migration Inhibitory Factor/CD 74-CD 44/p 38 MAPK Signaling in Lung Tissues].

Authors:  Jing Lu; Jing-Jing Xie; Shui-Ying Xiang; Yin Li; Wen-Juan Cong; Xian-Gang Lin; Zi-Bing Liu
Journal:  Zhen Ci Yan Jiu       Date:  2018-12-25

Review 5.  Acupuncture therapies for chronic obstructive pulmonary disease: a systematic review of randomized, controlled trials.

Authors:  Meaghan Elizabeth Coyle; Johannah Linda Shergis; Esther Tzu-Ya Huang; Xinfeng Guo; Yuan Ming Di; Anthony Zhang; Charlie Changli Xue
Journal:  Altern Ther Health Med       Date:  2014 Nov-Dec       Impact factor: 1.305

Review 6.  Inhaled corticosteroids for stable chronic obstructive pulmonary disease.

Authors:  Ian A Yang; Melissa S Clarke; Esther H A Sim; Kwun M Fong
Journal:  Cochrane Database Syst Rev       Date:  2012-07-11

7.  Acupuncture for chronic obstructive pulmonary disease (COPD): A multicenter, randomized, sham-controlled trial.

Authors:  Junfei Feng; Xuehui Wang; Xing Li; Dejun Zhao; Jinquan Xu
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

Review 8.  Global and regional estimates of COPD prevalence: Systematic review and meta-analysis.

Authors:  Davies Adeloye; Stephen Chua; Chinwei Lee; Catriona Basquill; Angeliki Papana; Evropi Theodoratou; Harish Nair; Danijela Gasevic; Devi Sridhar; Harry Campbell; Kit Yee Chan; Aziz Sheikh; Igor Rudan
Journal:  J Glob Health       Date:  2015-12       Impact factor: 7.664

9.  Long-term effects of acupuncture treatment on airway smooth muscle in a rat model of smoke-induced chronic obstructive pulmonary disease.

Authors:  Jia Li; Song Wu; Hongtu Tang; Wei Huang; Lushan Wang; Huanjiao Zhou; Miao Zhou; Hua Wang; Jing Li
Journal:  Acupunct Med       Date:  2015-09-07       Impact factor: 2.267

10.  Effects of acupuncture on nutritional state of patients with stable chronic obstructive pulmonary disease (COPD): re-analysis of COPD acupuncture trial, a randomized controlled trial.

Authors:  Masao Suzuki; Shigeo Muro; Motonari Fukui; Naoto Ishizaki; Susumu Sato; Tetsuhiro Shiota; Kazuo Endo; Tomoko Suzuki; Tadamichi Mitsuma; Michiaki Mishima; Toyohiro Hirai
Journal:  BMC Complement Altern Med       Date:  2018-10-24       Impact factor: 3.659

View more
  2 in total

1.  A Prognostic Model for the Respiratory Function of Patients with Nonsevere Pulmonary Infection Based on Breathing Exercises and Acupuncture Therapy: Development and Validation.

Authors:  Yulin Shi; Yong Hu; Guomeng Xu; Yaoqi Ke
Journal:  Comput Math Methods Med       Date:  2022-09-29       Impact factor: 2.809

2.  The effect of acupuncture on tumor growth and gut microbiota in mice inoculated with osteosarcoma cells.

Authors:  Xiaoru Xu; Xiangru Feng; Min He; Zepeng Zhang; Jiajia Wang; Haiyu Zhu; Tie Li; Fuchun Wang; Mengmeng Sun; Zhihong Wang
Journal:  Chin Med       Date:  2020-04-07       Impact factor: 5.455

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.